Top compounds associated with response to ZNF713


Feature Type Standardized
Nominal ANOVA
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.23 7e-11
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.24 1e-10
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 2e-10
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 6e-10
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 1e-09
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.2 1e-09
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.2 1e-09
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 4e-09
mRNA barasertib CTRPv2 pan-cancer AAC 0.19 7e-09
Download CSV